Silver Spike, Immutep, 8x8: 5 Top Stock Gainers for Thursday

Silver Spike, Immutep, 8x8, TG Therapeutics and TechTarget are five of the top stock gainers on Thursday.
Author:
Publish date:

Stocks finished mixed Thursday amid concerns about stalled stimulus negotiations and a disappointing report on jobless claims.

Here are some of the top gainers for Thursday:

1. Silver Spike Acquisition | Percentage Increase 37%

Blank-check company Silver Spike Acquisition  (SSPK) - Get Report climbed after agreeing to merge with WM Holding in a transaction that will take the cannabis technology company public. The deal to take the parent of Weedmaps public values the company at around $1.5 billion.

2. Immutep | Percentage Increase 163%

Immutep  (IMMP) - Get Report soared after the Australian biotech reported positive results from a trial of a treatment for metastatic breast cancer. The company said the treatment has shown an overall survival benefit in a random setting in metastatic breast cancer patients known to be insensitive to immune checkpoint inhibitor therapy.

3. 8x8 | Percentage Increase 35%

8x8  (EGHT) - Get Report surged after the integrated cloud communications platform provider named Dave Sipes as CEO and a member of the board. Sipes was most recently chief operating officer of RingCentral  (RNG) - Get Report. The company also affirmed guidance for the third quarter and fiscal 2021. 

4. TG Therapeutics | Percentage Increase 41%

TG Therapeutics  (TGTX) - Get Report was rising after the biopharma company announced positive top-line results from two Phase 3 studies for its ublituximab treatment of multiple sclerosis patients. Both studies met their primary endpoint, the company said. 

5. TechTarget | Percentage Increase 18%

TechTarget  (TTGT) - Get Report advanced after the internet content and information company said it had agreed to acquire BrightTALK, a marketing platform for webinars and virtual events in the enterprise IT market, for $150 million. The transaction is expected to close by the end of the year.